
In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection …

In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …

Cancer Research UK (CRUK) has announced a collaboration with Biotecnol, an immuno-oncology firm focused on the development of multifunctional antibodies …

The use of Almirall’s psoriasis drug Skilarence (dimethyl fumarate) on the UK’s NHS is one step closer after NICE gave …

A new study from the University of Eastern Finland has indicated that the use of proton pump inhibitors such as …

Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …

Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …

Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …

Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer …

A study originating out of Canada has laid bare the difference in cost of primary care prescription drugs between different …

The ABPI says the UK has an opportunity to benefit from stratified medicine, and the body’s 2014 conference held in …